关注
Eduardo Sprinz
Eduardo Sprinz
Hospital de Clínicas de Porto Alegre - FAMED - UFRGS
在 hcpa.edu.br 的电子邮件经过验证
标题
引用次数
引用次数
年份
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
53782021
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
P Braitstein, MW Brinkhof, F Dabis, M Schechter, A Boulle, P Miotti, ...
Lancet (London, England) 367 (9513), 817-824, 2006
13552006
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13492021
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 …
VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ...
The lancet Respiratory medicine 9 (12), 1407-1418, 2021
6742021
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
MWG Brinkhof, F Dabis, L Myer, DR Bangsberg, A Boulle, D Nash, ...
Bulletin of the World Health Organization 86 (7), 559-567, 2008
4312008
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
P Braitstein, A Boulle, D Nash, MWG Brinkhof, F Dabis, C Laurent, ...
Journal of women's health 17 (1), 47-55, 2008
2462008
Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies
D Nash, M Katyal, MWG Brinkhof, O Keiser, M May, R Hughes, F Dabis, ...
Aids 22 (17), 2291-2302, 2008
2372008
Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy
L Terry, E Sprinz, R Stein, NB Medeiros, J Oliveira, JP Ribeiro
Medicine & Science in Sports & Exercise 38 (3), 411-417, 2006
1892006
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring
ART-LINC of IeDEA Study Group
Aids 23 (14), 1867-1874, 2009
1812009
O conhecimento de HIV/aids na terceira idade: estudo epidemiológico no Vale do Sinos, Rio Grande do Sul, Brasil
AR Lazzarotto, AS Kramer, M Hädrich, M Tonin, P Caputo, E Sprinz
Ciência & Saúde Coletiva 13, 1833-1840, 2008
1702008
Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral …
SH Tuboi, MWG Brinkhof, M Egger, RA Stone, P Braitstein, D Nash, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (1), 52-59, 2007
1462007
Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: a cross-sectional study
RA Maciel, HM Klück, M Durand, E Sprinz
International Journal of Infectious Diseases 70, 30-35, 2018
1402018
Oxford COVID Vaccine Trial Group Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
Lancet 397 (10269), 99-111, 2021
1392021
Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy
O Keiser, P MacPhail, A Boulle, R Wood, M Schechter, F Dabis, E Sprinz, ...
Tropical Medicine & International Health 14 (10), 1220-1225, 2009
1152009
Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1–infected individuals: a randomized trial
RK Lazzaretti, R Kuhmmer, E Sprinz, CA Polanczyk, JP Ribeiro
Journal of the American College of Cardiology 59 (11), 979-988, 2012
1112012
Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil
SH Tuboi, LH Harrison, E Sprinz, RKM Albernaz, M Schechter
JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 324-328, 2005
1102005
Moderate and high intensity exercise training in HIV-1 seropositive individuals: a randomized trial
L Terry, E Sprinz, JP Ribeiro
International journal of sports medicine 20 (02), 142-146, 1999
1101999
Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil
AF Santos, TM Sousa, EAJM Soares, S Sanabani, AMB Martinez, ...
Aids 20 (16), 2011-2019, 2006
1052006
Cohort profile: antiretroviral therapy in lower income countries (ART-LINC): international collaboration of treatment cohorts
Antiretroviral Therapy in Lower Income Countries (ART-LINC) Study Group
International Journal of Epidemiology 34 (5), 979-986, 2005
1022005
HIV/AIDS e treinamento concorrente: a revisão sistemática
AR Lazzarotto, LF Deresz, E Sprinz
Revista Brasileira de Medicina do Esporte 16, 149-154, 2010
992010
系统目前无法执行此操作,请稍后再试。
文章 1–20